Genotoxic and cytotoxic activity of host defense peptides against human soft tissue sarcoma in an in vitro model

Drug and Chemical Toxicology

Volumn 35, Issue 1, 2012, Pages 96-103

  Steinstraesser, Lars ^a   Hauk, Jennifer ^a   Al Benna, Sammy ^a   Langer, Stefan ^b   Ring, Andrej ^b   Kesting, Marco ^c   Sudhoff, Holger ^d   Becerikli, Mustafa ^a   Käfferlein, Heiko ^b   Jacobsen, Frank ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Department of Otolaryngology Head and Neck Surgery ^*  (Germany)

Author keywords

antimicrobial peptide; Cancer; cytotoxicity; genotoxicity; oncolytic

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; PROTEGRIN; PROTEGRIN 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; COMET ASSAY; CONTROLLED STUDY; DRUG EFFICACY; FIBROBLAST; FIBROSARCOMA; GENOTOXICITY; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; SOFT TISSUE SARCOMA;

ANTIMICROBIAL CATIONIC PEPTIDES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; COMET ASSAY; DOXORUBICIN; FIBROBLASTS; FIBROSARCOMA; HUMANS; MUTAGENS; PEPTIDES;

EID: 83155193443     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480545.2011.589441     Document Type: Article

References (39)

1. Al-Benna, S., Steinstrasser, L. (2009). Postablative reconstruction is better terminology than oncoplastic surgery. Plast Reconstr Surg 124:463e-464e
2. Bitton, R. J., Guthmann, M. D., Gabri, M. R., Carnero, A. J., Alonso, D. F., Fainboim, L., et al. (2002). Cancer vaccines: An update with special focus on ganglioside antigens. Oncol Rep 9:267-276.
3. Boman, H.G.1995). Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13:61-92.
4. Cormier, J. N., Huang, X., Xing, Y., Thall, P. F., Wang, X., Benjamin, R. S., et al. (2004). Cohort analysis of patients with localized, highrisk, extremity soft tissue sarcoma treated at two cancer centers: Chemotherapy-associated outcomes. J Clin Oncol 22:4567-4574.
5. Donato Di Paola, E., Nielsen, O.S.2002). The EORTC soft tissue and bone sarcoma group. Eur J Cancer 38(Suppl 4):138-141.
6. Eilber, F. C., Eilber, F. R., Eckardt, J., Rosen, G., Riedel, E., Maki, R. G., et al. (2004). The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg 240:686-695; discussion, 695-697.
7. Finkelstein, S. E., Heimann, D. M., Klebanoff, C. A., Antony, P. A., Gattinoni, L., Hinrichs, C. S., et al. (2004). Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer. J Leukoc Biol 76:333-337.
8. Hanai, N., Nakamura, K., Shitara, K. (2000). Recombinant antibodies against ganglioside expressed on tumor cells. Cancer Chemother Pharmacol 46(Suppl):S13-S17.
9. Hirsch, T., Von Peter, S., Dubin, G., Mittler, D., Jacobsen, F., Lehnhardt, M., et al. (2006). Adenoviral gene delivery to primary human cutaneous cells and burn wounds. Mol Med 12:199-207.
10. Hoffmann, J. A., Kafatos, F. C., Janeway, C. A., Ezekowitz, R.A.1999). Phylogenetic perspectives in innate immunity. Science 284:1313-1318.
11. Jacobsen, F., Mohammadi-Tabrisi, A., Hirsch, T., Mittler, D., Mygind, P. H., Sonksen, C. P., et al. (2007). Antimicrobial activity of the recombinant designer host defence peptide P-novispirin G10 in infected full-thickness wounds of porcine skin. J Antimicrob Chemother 59:493-498.
12. Kakinuma, T., Nadiminti, H., Lonsdorf, A. S., Murakami, T., Perez, B. A., Kobayashi, H., et al. (2007). Small numbers of residual tumor cells at the site of primary inoculation are critical for anti-tumor immunity following challenge at a secondary location. Cancer Immunol Immunother 56:1119-1131.
13. Kokryakov, V. N., Harwig, S. S., Panyutich, E. A., Shevchenko, A. A., Aleshina, G. M., Shamova, O. V., et al. (1993). Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett 327:231-236.
14. Lai, J. R., Huck, B. R., Weisblum, B., Gellman, S. H.2002). Design of non-cysteine-containing antimicrobial beta-hairpins: structureactivity relationship studies with linear protegrin-1 analogues. Biochemistry 41:12835-12842.
15. Lehrer, R. I., Ganz,T.1999). Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 11:23-27.
16. Makovitzki, A., Fink, A., Shai, Y. (2009). Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides. Cancer Res 69:3458-3463.
17. Miyasaki, K. T., Lehrer, R. I.1998). Beta-sheet antibiotic peptides as potential dental therapeutics. Int J Antimicrob Agents 9:269-280
18. Nielsen, T. O., West, R. B., Linn, S. C., Alter, O., Knowling, M. A., O'Connell, J. X., et al. (2002). Molecular characterisation of soft tissue tumours: A gene expression study. Lancet 359:1301-1307.
19. Oren, Z., Shai, Y. (1997). Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Biochemistry 36:1826-1835.
20. Pan, J. G., Mak, T. W. (2007). Metabolic targeting as an anticancer strategy: dawn of a new era? Sci STKE 2007:pe14.
21. Papo, N., Braunstein, A., Eshhar, Z., Shai, Y. (2004). Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino acid peptide: Membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion. Cancer Res 64:5779-5786.
22. Papo, N., Seger, D., Makovitzki, A., Kalchenko, V., Eshhar, Z., Degani, H., et al. (2006). Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide. Cancer Res 66:5371-5378.
23. Papo, N., Shahar, M., Eisenbach, L., Shai, Y. (2003). A novel lytic peptide composed of DL-amino acids selectively kills cancer cells in culture and in mice. J Biol Chem 278:21018-21023.
24. Papo, N., Shai, Y. (2004). Effect of drastic sequence alteration and D-amino acid incorporation on the membrane binding behavior of lytic peptides. Biochemistry 43:6393-6403.
25. Papo, N., Shai, Y. (2005). Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci 62:784-790.
26. Reichardt, P. (2002). High-dose chemotherapy in adult soft tissue sarcoma. Crit Rev Oncol Hematol 41:157-167.
27. Restifo, N. P., Antony, P. A., Finkelstein, S. E., Leitner, W. W., Surman, D. P., Theoret, M. R., et al. (2002). Assumptions of the tumor 'escapé hypothesis. Semin Cancer Biol 12:81-86.
28. Sarcoma Meta-Analysis Collaboration. (1997). Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Lancet 350:1647-1654.
29. Singer, S., Demetri, G. D., Baldini, E. H., Fletcher, C.D.2000). Management of soft-tissue sarcomas: An overview and update. Lancet Oncol 1:75-85.
30. Smith, L. L., Brown, K., Carthew, P., Lim, C. K., Martin, E. A., Styles, J., et al. (2000). Chemoprevention of breast cancer by tamoxifen: Risks and opportunities. Crit Rev Toxicol 30:571-594.
31. Steinau, H. U., Homann, H. H., Drucke, D., Torres, A., Soimaru, D., Vogt, P. (2001). [Resection method and functional restoration in soft tissue sarcomas of the extremities]. Chirurg 72:501-513.
32. Steinstraesser, L., Burghard, O., Nemzek, J., Fan, M. H., Merry, A., Remick, D. I., et al. (2003). Protegrin-1 increases bacterial clearance in sepsis but decreases survival. Crit Care Med 31:221-226.
33. Steinstraesser, L., Kraneburg, U. M., Hirsch, T., Kesting, M., Steinau, H. U., Jacobsen, F., et al. (2009). Host defense peptides as effector molecules of the innate immune response: A sledgehammer for drug resistance? Int J Mol Sci 10:3951-3970.
34. Steinstraesser, L., Schubert, C., Hauk, J., Becerikli, M., Stricker, I., Koeller, M., et al. (2010). Oncolytic designer host defense peptide suppresses growth of human liposarcoma. Int J Cancer Epub Aug 23.
35. Tannock, I. F., Rotin, D. (1989). Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 49:4373-4384.
36. Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., Liu, L. F. (1984). Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226:466-468.
37. Vaupel, P., Kallinowski, F., Okunieff, P. (1989). Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 49:6449-6465.
38. Vezeridis, M. P., Moore, R., Karakousis, C.P.1983). Metastatic patterns in soft-tissue sarcomas. Arch Surg 118:915-918.
39. Zunino, F., Gambetta, R., Di Marco, A., Zaccara, A., Luoni,G.1975). A comparison of the effects of daunomycin and adriamycin on various DNA polymerases. Cancer Res 35:754-760.